TY  - GEN
AU  - Borazan,Mehmet
AU  - Karalezli,Aylin
AU  - Akova,Yonca Aydin
AU  - Akman,Ahmet
AU  - Kiyici,Halil
AU  - Erbek,Selim S
TI  - Efficacy of olopatadine HCI 0.1%, ketotifen fumarate 0.025%, epinastine HCI 0.05%, emedastine 0.05% and fluorometholone acetate 0.1% ophthalmic solutions for seasonal allergic conjunctivitis: a placebo-controlled environmental trial
SN  - 1755-3768
PY  - 2009///1106
KW  - Adolescent
KW  - Adult
KW  - Anti-Allergic Agents
KW  - administration & dosage
KW  - Benzimidazoles
KW  - Child
KW  - Conjunctival Diseases
KW  - drug therapy
KW  - Conjunctivitis, Allergic
KW  - Dibenzazepines
KW  - Dibenzoxepins
KW  - Double-Blind Method
KW  - Edema
KW  - Eyelid Diseases
KW  - Female
KW  - Fluorometholone
KW  - Histamine H1 Antagonists
KW  - Humans
KW  - Imidazoles
KW  - Ketotifen
KW  - Male
KW  - Middle Aged
KW  - Olopatadine Hydrochloride
KW  - Ophthalmic Solutions
KW  - Prospective Studies
KW  - Pruritus
KW  - prevention & control
KW  - Seasons
KW  - Tears
KW  - drug effects
KW  - Treatment Outcome
KW  - Young Adult
N1  - Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial
UR  - https://doi.org/10.1111/j.1755-3768.2008.01265.x
ER  -